Review Article
Safety in Subsequent Lines of Therapy in Patients With Relapsed Refractory Follicular Lymphoma
Tajuana Bradley, MS, FNP-BC, Mark Davis, MPAS, PA-C, Julie Martin, DNP, AOCN, NP, et al.
November 5, 2024
What Do Patients With Cancer Know, or Want to Know, About Genomic Tumor Sequencing and Genetic Testing? A State-of-the-Art Review
Lisa Stewart, PhD, ACNP, AOCNP, Linda D. Ward, PhD, APN, FNP-C
September 11, 2024
Seamless Navigation of Bispecific Therapies: Optimizing Management and Outpatient Access With a Focus on Coordination
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, Amir Ali, PharmD, BCOP, James Davis, PharmD, BCOP, et al.
September 11, 2024
Diversity, Equity, and Inclusion in Multiple Myeloma: A Call to Action
Rebecca Lu, MSN, FNP-C, Joseph D. Tariman, PhD, MBA, ANP-BC, FAAN, Donna Catamero, ANP-BC, OCN, CCRC, et al.
July 22, 2024
Interaction of the Gut Microbiome With Cancer Treatment
Paula M. Barrenechea, MPAS, PA-C
July 19, 2024
The Effect of Music Therapy as an Adjunctive Treatment in Pediatric Cancer Patients Receiving Traditional Therapies: A Systematic Review
Debra M. Cole, EdD, PA-C, DFAAPA, Kaitlin Beane, PA-S, Madeleine Engel, PA-S, et al.
May 22, 2024
How Can Oncology Nurses and Advanced Practice Providers Reduce the Burden of Chemotherapy-Induced Febrile Neutropenia in the US?
Kristi Kay Orbaugh, MSN, NP, AOCNP, Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP, Lisa Kennedy Sheldon, PhD, APRN-BC, AOCNP®, FAAN et al.
May 22, 2024
Growth Factor in the Setting of CAR T-Cell Therapy: To Use or Not to Use
Cindy L. Cao, DNP, APRN, AGPCNP-C, AOCNP®, OCN®, BMTCN, Ashley Martinez, DNP, APRN, FNP-BC, AOCNP®, CBCN, CPHQ, NEA-BC, NPD-BC, Joyce Dains, DrPH, JD, RN, FNP-BC, FNAP, FAANP, FAAN et al.
May 21, 2024
Risk Factors for Immune Checkpoint Inhibitor–Related Myocarditis: An Integrative Review
Sara M. Otto, MS, APRN, FNP-BC, AOCNP®, Ashely L. Martinez, DNP, APRN, FNP-BC, AOCNP®, CBCN, CPHQ, NEA-BC, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP, FAAN
March 25, 2024
Practical Management of Adverse Events Associated With FGFR Inhibitors for Cholangiocarcinoma for the Advanced Practice Provider
Gabriel Schwartz, MSN, FNP-BC, AOCNP, Julianne O. Darling, PharmD, BCOP
February 14, 2024
Peripheral T-Cell Lymphoma, Not Otherwise Specified: Diagnosis and Therapeutic Approaches for the Advanced Practice Provider
Karla V. Ow, MSN, APRN, AOCNP, Ann Vo, MSN, APRN, FNP, Jonathan Cunningham, MPAS, PA-C et al.
February 14, 2024
Does Use of Intratumoral Injections in Solid Tumor Malignancies Improve Outcomes and Reduce Adverse Events? An Integrative Review
Maggie Matyola, APRN, FNP-C, Ashley Martinez, DNP, APRN, FNP-BC, Joyce Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP, FAAN
January 24, 2024
Impact of Fasting on Patients With Cancer: An Integrative Review
Samantha Thompson, MPH, MCHS, PA-C, Lydia T. Madsen, PhD, RN, AOCNS®, FNAP, and Angela Bazzell, DNP, APRN, FNP-BC, AOCNP®
November 29, 2023
Role of Preemptive Cytomegalovirus Hyperimmunoglobulin in Cytomegalovirus Viremia Following Stem Cell Transplant: An Integrative Review
Jaci Whittaker, MSN, APRN, FNP-BC, Ashley Martinez, DNP, APRN, FNP-BC, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FANP, FAANP, FAAN
November 29, 2023
Advanced Practitioners as Agents of Change: Leveraging Quality Improvement to Improve Practice
Sandra Kurtin,(1) PhD, ANP-BC, AOCN®, FAPO, Andrea Edwards,(2) PA-C, Heather Koniarczyk,(3) MSN, APRN-CNP, AOCNP®, Camille Petraitis,(4) DNP, FNP-BC, Lisa Nodzon,(5) PhD, APRN, AOCNP®, Nicole Deline,(6) MSN, APRN, FNP-C, AOCNP®, Tajuana Bradley,(7) FNP-BC, Megan May,(8) PharmD, BCOP, FAPO, FHOPA, Molly Thompson-Coffey,(9) Jessica Tamasi,(9) and Wendy Vogel,(10) MSN, FNP, AOCNP®, FAPO
November 8, 2023
Role of the Advanced Practitioner in Clinical Research
Christa Marie Braun-Inglis,(1) DNP, APRN, FNP-BC, AOCNP®, Brianna Hoffner,(2) MSN, ANP-BC, AOCNP®, FAPO, Lisa Kottschade,(3) APRN, MSN, CNP, FAPO, Erin Pierce,(4) MSN, APRN, FNP-C, and Sandra Kurtin,(5) PhD, ANP-BC, AOCN®, FAPO
November 8, 2023
APSHO Oncology/Hematology Advanced Practitioner Compensation Survey
Wendy Vogel,(1) MSN, FNP, AOCNP®, FAPO, Yi Lisa Hwa,(2) APRN, DNP, CNP, FAPO, Lisa Kottschade,(2) APRN, MSN, CNP, FAPO, and Megan May,(3) PharmD, BCOP, FAPO, FHOPA
November 8, 2023
Understanding Advanced Practitioner Prescriptive Privileges for Anticancer Therapies: A National Survey
Archana Ajmera,(1) MSN, ANP-BC, AOCNP®, Leigh Boehmer,(2) PharmD, BCOP, Christa Marie Braun-Inglis,(3) DNP, APRN, FNP-BC, AOCNP®, Brianna Hoffner,(4) MSN, ANP-BC, AOCNP®, FAPO, Maria Matta,(2) MPH, and Rana R. McKay,(1) MD
November 6, 2023
Pancreatic Cancer and the Family Connection: The Role of Advanced Practitioners in Screening and Educating Genetically At-Risk Individuals
Tracy Lowe,(1) PhD, MS, RN, Jane DeLuca,(1) PhD, MS, RN, CPNP-PC, Ludovico Abenavoli,(2) MD, PhD, MSc, and Luigi Boccuto,(1) MD
September 20, 2023
Post-Transplant Cyclophosphamide for the Prevention of Graft-vs.-Host Disease in Allogeneic Hematopoietic Cell Transplantation: A Guide to Management for the Advanced Practitioner
Ekaterina Kachur, PharmD, BCOP, Jai N. Patel, PharmD, BCOP, CPP, Allison L. Morse, PharmD, BCOP, Donald C. Moore, PharmD, BCPS, BCOP, DPLA, FCCP, and Justin R. Arnall, PharmD, BCOP
September 19, 2023
Quality of Life in Adult Cancer Patients With Underage Children: An Integrative Review
Gabriela Mota-George, MSN, APRN, FNP-BC, AOCNP®, Ashley Martinez, DNP, APRN, FNP-BC, AOCNP®, CBCN, CPHQ, NEA-BC, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP
July 17, 2023
Management of Ocular Toxicity in Patients Receiving Belantamab Mafodotin
Rebecca Lu, MSN, FNP-C, Ashley Morphey, RN, MSN, CCRP, Felicia Diaz, MSN, APRN, FNP-BC, AOCNP®, Jessica Chen, RN, MSN, OCN®, FNP-C, Azadeh Razmandi, OD, FAAO, and Tiffany Richards, PhD, ANP-BC, AOCNP®
May 23, 2023
Rethinking Medical Aid in Dying: What Does It Mean to ‘Do No Harm?’
Dallas R. Lawry, DNP, FNP-C, AOCNP®
May 23, 2023
Revolutionizing Cancer Treatment: Harnessing the Power of Biomarkers to Improve Patient Outcomes
Donald C. Moore,(1) PharmD, BCPS, BCOP, DPLA, FCCP, and Andrew S. Guinigundo,(2) MSN, RN, CNP, ANP-BC
April 26, 2023
Biomarker-Driven Oncology Clinical Trials: Novel Designs in the Era of Precision Medicine
Donald C. Moore,(1) PharmD, BCPS, BCOP, DPLA, FCCP, and Andrew S. Guinigundo,(2) MSN, RN, CNP, ANP-BC
April 26, 2023
The Role of Biomarkers in Guiding Clinical Decision-Making in Oncology
Donald C. Moore,(1) PharmD, BCPS, BCOP, DPLA, FCCP, and Andrew S. Guinigundo,(2) MSN, RN, CNP, ANP-BC
April 26, 2023
The Advanced Practitioner’s Role in the Rapidly Evolving Landscape of Precision Medicine
Donald C. Moore,(1) PharmD, BCPS, BCOP, DPLA, FCCP, and Andrew S. Guinigundo,(2) MSN, RN, CNP, ANP-BC
April 26, 2023
Tisotumab Vedotin Safety and Tolerability in Clinical Practice: Managing Adverse Events
Courtney R. Arn,(1) APRN-CNP, Kimberly J. Halla,(2) MSN, FNP-C, and Sally Gill,(3) RN (Hons)
March 22, 2023
Physical Activity in Multiple Myeloma: A Review of the Current Literature
Michaela Hillengass,(1) RN, ACSM-CPT, Janine Joseph,(1) MS, MBA, Jane McCarthy, and Jens Hillengass,(1) MD, PhD
March 22, 2023
The Role of the Research Advanced Practice Provider in CAR T-Cell Clinical Trials
Ly Dsouza, PA-C, MPAS
January 18, 2023
Liquid Biopsy for Guiding Treatment Decisions in Advanced Non–Small Cell Lung Cancer
Gretchen Suk, DMSc, PA-C
November 21, 2022
Meta-Analysis of Same-Day Pegfilgrastim Administration Stratified by Myelotoxic Febrile Neutropenia Risk and Tumor Type
Neda Alrawashdh,(1,2) PhD, PharmD, Ali McBride,(3) PharmD, MS, BCPS, Mok Oh,(1) PhD, PharmD, Nimer Alkhatib,(1) PhD, PharmD, Christopher Lee,(4) PhD, RN, FAHA, FAAN, FHFSA, Jennifer Martin,(5) MA, Karen MacDonald,(6) PhD, RN, and Ivo Abraham,(1,3,6) PhD, RN
November 21, 2022
Ultrasound Evaluation of Carotid Artery Intima-Media Thickness: Effective Early Marker of Carotid Artery Disease in Adult Head and Neck Cancer Patients After Neck Radiation?
Whitney Randolph, APRN, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP
September 20, 2022
The Role of Echocardiogram and Cardiac Rhythm Analysis for Early Detection of Cardiac Amyloidosis
Elizabeth Hubert, APRN, FNP-C, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP
September 20, 2022
Barriers to Adherence to Cancer Treatments Among Head and Neck Cancer Patients
Jennifer Lynn Miller, PhD, RN, CMSRN, and Julianne Evers, DNP, APRN, AGACNP-BC, CCRN
July 20, 2022
Measuring Advanced Practice Provider Productivity at the National Comprehensive Cancer Network’s Member Institutions
Diana Krause(1), Karen Sharrah(2), Anne Gross(3), Danielle Bowers(3), Daniel Mulkerin(4), Nancy Brandt(4), Kate Kennedy(5), Annie Austin(5), Aaron Begue(6), Rose Bell(7), Cheryl Raczyk(7), Todd Pickard(8), Timothy Kubal(9), Dave Johnson(9), Kellyann Jeffries(10), Vanna Dest(11), Rory Randall(12), Jessica Sugalski(1), and Gabrielle Zecha(13)
July 18, 2022
Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life
Miguel A. Escobar,(1) MD, Cindy Leissinger,(2) MD, and Guy Young,(3) MD
May 25, 2022
Practical Management of the Venetoclax-Treated Patient in Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
Matthew Waggoner,(1) MS, John Katsetos,(1) PA-C, Emilee Thomas,(1) MBA, MPH, PA-C, Ilene Galinsky,(2) BSN, MSN, ANP-C, and Heather Fox,(3) PA-C
May 18, 2022
Practical Strategies for Advanced Practitioners Streamlining the Integration of Oncology Biosimilar Therapies Into Practice
Kelley D. Mayden,(1) DNP, APRN-FNP, AOCNP®, John M. Kelton,(2) PharmD, Joanne C. Ryan,(2) PhD, RN, and Ali McBride,(3,4) PharmD, BCPS, BCOP
May 18, 2022
Cardiovascular Adverse Events and Mitigation Strategies for Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy
Lisa Nodzon, PhD, APRN, AOCNP®, Anecita Fadol, PhD, FNP-BC, FAANP, FAAN, and Sara Tinsley, PhD, APRN, AOCN®
March 19, 2022
Evidence-Based Criteria Supporting Early Discharge for Pediatric Patients With Osteosarcoma Receiving High-Dose Methotrexate: A Retrospective Chart Review
Erin Armideo, CRNP, MSN, BSN, RN, CPON, Shannon Froio, BSN, RN, Meredith Johnson, CRNP, MSN, BSN, RN, Alison Tardino-Gingrich, CRNP, MSN, BSN, RN, and Elizabeth Froh, PhD, RN
March 19, 2022
Emerging Treatment Options for Advanced or Recurrent Endometrial Cancer
Kimberly Halla, FNP-C
January 19, 2022
Antibiotic Therapy and Gastrointestinal Graft-Versus-Host Disease in the Allogeneic Stem Cell Transplantation Population
Jessica Thomas, MSN, APRN, FNP-C, AOCNP®, Christi Bowe, MSN, APRN, ANP-C, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP
January 19, 2022
Premedications for Cancer Therapies: A Primer for the Hematology/Oncology Provider
Amber Clemmons,(1,2) PharmD, BCOP, Arpita Gandhi,(3) PharmD, BCOP, Andrea Clarke,(2) PharmD, Sarah Jimenez,(2) APN-BC, AGACNP, AOCNP®, Thuy Le,(2) MD, and Germame Ajebo,(2) MD
November 24, 2021
Telehealth Interventions for Supportive Management and Early Recognition of Treatment-Related Symptoms in Patients With Hematologic Malignancies
Chasity Yajima, MSN, APRN, FNP-C, AOCNP®, Christi Bowe, DNP, APRN, ANP-C, NPD-BC, CPHQ, Diane Barber, PhD, APRN, ANP-BC, AOCNP®, FAANP, FAAN, and Joyce Dains, DrPH, JD, APRN, FNP-BC, FAANP, FAAN
November 24, 2021
CDK4/6 Inhibitors: Paving the Way for HR-Positive, HER2-Negative Early Breast Cancer
Kristi Orbaugh,(1) RN, MSN, RNP, AOCN®, Val R. Adams,(2) PharmD, FCCP, BCOP, FHOPA, and Theresa W. Gillespie,(3) PhD, MA, RN, FAAN
November 23, 2021
Early Detection of Vulvovaginal Graft-Versus-Host Disease: An Integrative Review
Payton L. Ten Hagen, DNP, APRN, FNP-C, Christi Bowe, MSN, APRN, ANP-C, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP
September 22, 2021
A Study of Advanced Practice Provider Staffing Models and Professional Development Opportunities at National Comprehensive Cancer Network Member Institutions
Annie Austin,(1) Kellyann Jeffries,(2) Diana Krause,(3) Jessica Sugalski,(3) Karen Sharrah,(4) Anne Gross,(5) Danielle Bowers,(5) Daniel Mulkerin,(6) Nancy Brandt,(6) Aaron Begue,(7) Rose Bell,(8) Cheryl Raczyk,(8) Todd Pickard,(9) David Johnson,(10) Vanna Dest,(11) Rory Randall,(12) Gabrielle Zecha,(13) and Kate Kennedy,(1)
September 21, 2021
Treatment Options for Germline BRCA-Mutated Metastatic Pancreatic Adenocarcinoma
Doreen Grzelak, NP-C, AOCN®, AGN-BC
July 12, 2021
Nipple-Sparing Mastectomy in Breast Cancer: Impact on Surgical Resection, Oncologic Safety, and Psychological Well-Being
Lisa Parks, MS, APRN-CNP, ANP-BC
July 12, 2021
Management of Hematologic Adverse Events Associated With Immune Checkpoint Inhibitors
Barbara Barnes Rogers, CRNP, MN, AOCN®, ANP-BC, Carolyn Zawislak, MPAS, PA-C, and Victoria Wong, PA-C
May 19, 2021
Ginseng for the Management of Cancer-Related Fatigue: An Integrative Review
Emily A. Lemke, DNP, AGPCNP-BC, AOCNP®
May 19, 2021
The Use of Real-World Evidence for Oral Chemotherapies in Breast Cancer
Kirollos Hanna,(1) PharmD, BCPS, BCOP, and Kelley Mayden,(2) MSN, FNP, AOCNP®
March 24, 2021
Chemotherapy Treatment Considerations in Metastatic Breast Cancer
Kirollos Hanna,(1) PharmD, BCPS, BCOP, and Kelley Mayden,(2) MSN, FNP, AOCNP®
March 23, 2021
Integration of Palliative Care in the Role of the Oncology Advanced Practice Nurse
Betty R. Ferrell,(1) RN, PhD, MA, FAAN, FPCN, CHPN, Rose Virani,(1) RNC, MHA, FPCN, Elinor Han,(1) BA, and Polly Mazanec,(2) PhD, ACNP-BC, AOCN®, FPCN, FAAN
March 17, 2021
Patient-Reported Outcome Measures With Secondary Lower Limb Lymphedemas: A Systematic Review
Margit Eidenberger, PT Mag
March 17, 2021
Roadmap to the Enhanced Thoracic Surgical Journey
TaCharra Y. D. Woodard, MSN, APRN, ACNP-BC, AOCNP®, Carla M. Patel, MSN, APRN, ACNP-BC, and Garrett L. Walsh, MD
January 19, 2021
The Impact of Peripheral Cooling on Chemotherapy-Induced Peripheral Neuropathy: An Integrative Review
Bethany G. Sphar, MSN, APRN, FNP-C, AOCNP®, Christi Bowe, DNP, APRN, ANP-C, NPD-BC, CPHQ, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP
November 17, 2020
Pancreatic Ductal Adenocarcinoma: Characteristics of Tumor Microenvironment and Barriers to Treatment
Sujata Kane,(1) PA-C, Anne Engelhart,(1) ANP-BC, Jessica Guadagno,(1) PA-C, Aaron Jones,(1) ANP-BC, Innis Usoro,(2) and Edith Brutcher,(1) ANP-BC, AOCNP®
September 23, 2020
Nausea and Vomiting Not Related to Cancer Therapy: Intractable Problem or Clinical Challenge?
Rita J. Wickham, PhD, RN
July 22, 2020
Phase 1 Clinical Trials in the Elderly: Enrollment Challenges
Carol Guarnieri, RN, MSN, FNP-C, and Daniel D. Von Hoff, MD, FACP, FASCO, FAACR
July 22, 2020
Risk Factors for Ifosfamide-Related Encephalopathy in Adult Cancer Patients: An Integrative Review
Amanda Lee Brink, DNP, APRN, FNP-BC, AOCNP®, Christi Bowe, MSN, APRN, ANP-C, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP
May 27, 2020
Beyond CAR T-Cell Therapy: Continued Monitoring and Management of Complications
Victoria Reiser, RN, BSN, BMTCN, OCN®
March 18, 2020
Optimizing Use of Newly Approved Agents for Acute Myeloid Leukemia
Nancy M. Nix, PharmD, BCPS, BCOP, and Allyson Price, MPAS, PA-C
December 23, 2019
The Role of the Advanced Practitioner in Enhancing Outcomes
Nancy M. Nix, PharmD, BCPS, BCOP, and Allyson Price, MPAS, PA-C
December 23, 2019
AL Amyloidosis: Unfolding a Complex Disease
Rebecca Lu, MS, FNP, and Tiffany A. Richards, PhD, ANP-BC
November 20, 2019
Aztreonam and Vancomycin for Initial Treatment of Febrile Neutropenia in Penicillin-Allergic Patients During Hematopoietic Stem Cell Transplantation
Steven Trifilio, RPh, and Jayesh Mehta, MD
September 18, 2019
Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach
Yi L. Hwa, DNP,(1) Teresa Fogaren, MSN, AGNP-C,(2) Allison Sams, AGPCNP-BC,(3) Douglas V. Faller, MD, PhD,(4) Dawn M. Stull, PharmD, BCOP,(5) Sara Thuenemann, RN, MSN, DHSc,(6) and Lisa Mendelson, MSN, AGPCNP-BC(7)
July 22, 2019
Cardiac Toxicity and Anthracyclines: Mechanism, Interventions, and the Trouble With Troponin
Grace E. Thompson, MSN, AGACNP-BC, AGPCNP-BC, and Phyllis P. Wright, DNP, AGPCNP-BC, MPH
May 21, 2019
The Advanced Practice Provider Perspective: Treating Patients With Immuno-Oncology Combination Therapy Across Tumor Types
Brianna Hoffner,(1) MSN, ANP-BC, AOCNP®, Renae Vaughn,(2) MSN, ANP-C, AOCNP®, Maureen Reed,(3) MSN, ANP-C, AOCNP®, and Melinda S. Weber,(4) DNP, RN, APN, AOCN®
May 21, 2019
Anti-CD19 CAR T-Cell Therapy for Adult Patients With Refractory Large B-Cell Lymphoma
Kathleen McDermott, RN, BSN, OCN®, BMTCN®, and Lauren Spendley, AGNP, MSN, AOCN®
May 21, 2019
Educating Multidisciplinary Care Teams, Patients, and Caregivers on CAR T-Cell Therapy
Alix Beaupierre, RN, BSN, OCN®, Nicole Kahle, MS, RN, OCN®, BMTCN®, Rachel Lundberg, PA-C, MPAS, and Amy Patterson, MSN, APRN, AOCNS®, BMTCN®
May 21, 2019
Adverse Effects of Virus-Specific T-Cell Therapy: An Integrative Review
Heidi Z. Simmons, MSN, RN, FNP-C, Angela F. Bazzell, DNP, RN, FNP-BC, AOCNP®, and Joyce E. Dains, DrPH, JD, RN, FNP-BC
March 24, 2019
Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
Brianna Hoffner, MSN, ANP-BC, AOCNP®, and Krista M. Rubin, MS, FNP-BC
March 17, 2019
PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP®
March 17, 2019
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
Laura S. Wood, RN, MSN, OCN®
March 17, 2019
Botulinum Toxin for Side-Effect Management and Prevention of Surgical Complications in Patients Treated for Head and Neck Cancers and Esophageal Cancer
Leah Shaw, MSN, RN, AGPCNP-BC, AOCNP®, Angela F. Bazzell, DNP, RN, FNP-BC, AOCNP®, and Joyce E. Dains, DrPH, JD, RN, FNP-BC, FNAP, FAANP
January 21, 2019
Breast Implant–Associated Anaplastic Large Cell Lymphoma: What We Know
Nadia E. K. DePaola, MS, PA-C, and Heather Coggins, MS, PA-C
January 21, 2019
Potential of Biosimilars to Increase Access to Biologics: Considerations for Advanced Practice Providers in Oncology
Sara M. Tinsley,(1) PhD, ARNP, AOCN®, Carolyn Grande,(2) CRNP, AOCNP®, Karin Olson,(3) PhD, PA-C, Leah Plato,(4) PA-C, MPH, CCRP, and Ira Jacobs,(5) MD, JD, MBA, FACS
November 27, 2018
Diagnosis, Evaluation, and Surgical Management of Melanoma
Brianna Hoffner, MSN, ANP-BC, AOCNP®, and Christan G. Bartsch, MSHS, PA-C, MPH
November 27, 2018
Harnessing the Immune System in the Treatment of Melanoma
Suzanne McGettigan, MSN, CRNP, AOCN®
November 27, 2018
BRAF/MEK Inhibition in Melanoma: An Update
Lisa A. Kottschade, APRN, MSN, CNP, and Kathleen M. Madden, RN, MSN, FNP-BC, AOCNP®, APHN
November 27, 2018
Melanomas of Noncutaneous Origin: Diagnosis, Treatment, and Outcomes
Lisa A. Kottschade, APRN, MSN, CNP
November 27, 2018
Supportive Care and Management of Treatment-Related Adverse Effects From Immune Checkpoint Inhibitors and Targeted Therapies in Melanoma
Krista M. Rubin, MS, FNP-BC, and Lisa A. Kottschade, APRN, MSN, CNP
November 27, 2018
Systemic Treatments for Lung Cancer Patients Receiving Hemodialysis
Tzewah V. Leung, PharmD, BCOP, Mitchell E. Hughes, PharmD, BCPS, BCOP, Christine G. Cambareri, PharmD, BCPS, BCOP, Daniel J. Rubin, PharmD, and Beth Eaby-Sandy, MSN, CRNP, OCN®
September 14, 2018
Hypercalcemia of Malignancy
Kaitlin L. Feldenzer,(1) DNP, RN, OCN®, and Jessica Sarno,(2) MSN, ACNP-BC, AOCNP®
July 24, 2018
Enhanced Recovery After Surgery
Lisa Parks,(1) MS, RN, CNP, Meghan Routt,(2) MSN, ANP/GNP-BC, AOCNP®, and Allison De Villiers,(1) MSN, RN, OCN®, ACNS-BC
July 24, 2018
Current Issue
Immediate Patient Access to Test Results and the Impact on Advanced Practitioners
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
November 26, 2024
Obinutuzumab Infusion-Related Reactions Multicenter Retrospective Evaluation of Incidence, Severity, and Risk Factors
Erin Hickey Zacholski, PharmD, BCOP, Sarah Rugh, PharmD Candidate, Jenna Marshall, PharmD Candidate, Et al.
November 26, 2024
Pancreatic Cancer The Advanced Practitioners Role in Early Diagnosis and Management
Lindsay Knox, FNP-C
November 26, 2024